United States Pharmaceuticals & Healthcare Report Q2 2018

United States Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Tax reform in the US will influence many areas of pharmaceutical company activity in 2018, but will not bring the fullrange of benefits expected by some stakeholders. Although the statutory corporate tax rate will almost halve, the average effectiverate will only decline by a few percentage points. Other countries are also lowering their tax rates, and the full details of the changesin the US have yet to be fully considered. In addition, many foreign firms that generate high levels of profit in the US are alsobenefitting from the reforms.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Pharmaceuticals & Healthcare Risk/Reward Index
US To Remain The Most Attractive Pharmaceutical Market Globally
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Eli Lilly
Merck & Co
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook